The next generation of platinum drugs: targeted Pt (II) agents, nanoparticle delivery, and Pt (IV) prodrugs

TC Johnstone, K Suntharalingam, SJ Lippard - Chemical reviews, 2016 - ACS Publications
The platinum drugs, cisplatin, carboplatin, and oxaliplatin, prevail in the treatment of cancer,
but new platinum agents have been very slow to enter the clinic. Recently, however, there …

Cellular processing of platinum anticancer drugs

D Wang, SJ Lippard - Nature reviews Drug discovery, 2005 - nature.com
Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in
cancer chemotherapy. Platinum–DNA adducts, which are formed following uptake of the …

Molecular mechanisms of resistance and toxicity associated with platinating agents

CA Rabik, ME Dolan - Cancer treatment reviews, 2007 - Elsevier
Platinating agents, including cisplatin, carboplatin, and oxaliplatin, have been used clinically
for nearly 30years as part of the treatment of many types of cancers, including head and …

Direct cellular responses to platinum-induced DNA damage

Y Jung, SJ Lippard - Chemical reviews, 2007 - ACS Publications
Since the serendipitous discovery of the biological activity of cisplatin, 1 the drug has been
applied extensively in cancer chemotherapy. 2 Platinum-based drugs such as cisplatin …

Mechanisms of resistance to cisplatin

M Kartalou, JM Essigmann - Mutation Research/Fundamental and …, 2001 - Elsevier
The use of cisplatin in cancer chemotherapy is limited by acquired or intrinsic resistance of
cells to the drug. Cisplatin enters the cells and its chloride ligands are replaced by water …

Cisplatin and oxaliplatin: our current understanding of their actions

IA Riddell, SJ Lippard - Met. Ions Life Sci, 2018 - degruyter.com
Following the serendipitous discovery of the anticancer activity of cisplatin over 50 years
ago, a deep understanding of the chemical and biochemical transformations giving rise to its …

Cisplatin: from DNA damage to cancer chemotherapy

SM Cohen, SJ Lippard - 2001 - Elsevier
Abstract Cisplatin [cis-DDP, cis-diamminedichloroplatinum (II)] is a potent anticancer drug
that has been used successfully to treat tumors of the head, neck, lungs, and genitourinary …

Cisplatin DNA damage and repair maps of the human genome at single-nucleotide resolution

J Hu, JD Lieb, A Sancar, S Adar - Proceedings of the …, 2016 - National Acad Sciences
Cisplatin is a major anticancer drug that kills cancer cells by damaging their DNA. Cancer
cells cope with the drug by removal of the damages with nucleotide excision repair. We have …

Cellular and molecular pharmacology of oxaliplatin

E Raymond, S Faivre, S Chaney, J Woynarowski… - Molecular cancer …, 2002 - AACR
Oxaliplatin, a diaminocyclohexane-containing platinum, has a spectrum of activity and
mechanisms of action and resistance that appear to be different from those of other platinum …

Organic cation transporters are determinants of oxaliplatin cytotoxicity

S Zhang, KS Lovejoy, JE Shima, LL Lagpacan, Y Shu… - Cancer research, 2006 - AACR
Although the platinum-based anticancer drugs cisplatin, carboplatin, and oxaliplatin have
similar DNA-binding properties, only oxaliplatin is active against colorectal tumors. The …